Filing Details

Accession Number:
0001219036-14-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-20 17:33:53
Reporting Period:
2014-02-18
Filing Date:
2014-02-20
Accepted Time:
2014-02-20 17:33:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219036 S Jerry Lanchbury 320 Wakara Way
Salt Lake City UT 84108
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-18 10,000 $13.28 27,551 No 4 M Direct
Common Stock Disposition 2014-02-18 10,000 $34.55 17,551 No 4 S Direct
Common Stock Acquisiton 2014-02-18 24,192 $12.17 41,743 No 4 M Direct
Common Stock Disposition 2014-02-18 24,192 $34.55 17,551 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-02-18 24,192 $0.00 24,192 $12.17
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-02-18 10,000 $0.00 10,000 $13.28
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-02-21 No 4 M Direct
54,676 2018-02-28 No 4 M Direct
Footnotes
  1. The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.